돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 856250생성일: 2026년 10월 24일

Dimethylformamide → 2-Methyl-6-nitro-2-[4-(4-trifluoromethylbenzoyl)piperidin-1-yl]methyl-2,3-dihydroimidazo[2,1-b]oxazole

https://huagongshe.com/ko/reaction/856250

반응식

참여 물질

역할이름HCID투입량
반응물DimethylformamideHCID 6228—
반응물Sodium AcetateHCID 517045—
반응물4-(4-Trifluoromethylbenzoyl)piperidineHCID 11637455—
반응물2-Chloro-1-(2-methyloxiran-2-ylmethyl)-4-nitroimidazoleHCID 15965523—
용매WaterHCID 962—
생성물2-Methyl-6-nitro-2-[4-(4-trifluoromethylbenzoyl)piperidin-1-yl]methyl-2,3-dihydroimidazo[2,1-b]oxazoleHCID 6948309329%

반응 조건

온도80 °C

반응 단계

A mixture of 2-chloro-1-(2-methyloxiran-2-ylmethyl)-4-nitroimidazole prepared in Example 6 (80 mg, 0.37 mmol), 4-(4-trifluoromethylbenzoyl)piperidine (95 mg, 0.37 mmol), sodium acetate (150 mg, 1.83 mmol) and DMF (2 ml) was stirred at 80° C. overnight. The reaction mixture was poured into water, and extracted with ethyl acetate twice. The organic phases were combined, washed with water three times, washed with a saturated saline solution, dried over sodium sulfate and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate/n-hexane=1/1) to afford 2-methyl-6-nitro-2-[4-(4-trifluoromethylbenzoyl)piperidin-1-yl]methyl-2,3-dihydroimidazo[2,1-b]oxazole (46 mg, yield 29%) as a white powder.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07262212B2
출처 데이터셋uspto-grants-2007_08
ORD IDord-20cf7a1eeea74674948a0059cc2514ee
출처 메모uspto-grants-2007_08